Shenghan Wang

481 total citations
26 papers, 298 citations indexed

About

Shenghan Wang is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Infectious Diseases. According to data from OpenAlex, Shenghan Wang has authored 26 papers receiving a total of 298 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Pulmonary and Respiratory Medicine and 4 papers in Infectious Diseases. Recurrent topics in Shenghan Wang's work include SARS-CoV-2 and COVID-19 Research (2 papers), Tracheal and airway disorders (2 papers) and Pancreatic and Hepatic Oncology Research (2 papers). Shenghan Wang is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (2 papers), Tracheal and airway disorders (2 papers) and Pancreatic and Hepatic Oncology Research (2 papers). Shenghan Wang collaborates with scholars based in China, Germany and Taiwan. Shenghan Wang's co-authors include Shiou‐Hwei Yeh, Pei‐Jer Chen, Hurng‐Yi Wang, Wei–Hsiang Lin, Ding‐Shinn Chen, Ayse Ceren Mutgan, Helmut Frieß, İhsan Ekin Demir, Güralp O. Ceyhan and Meihui Luo and has published in prestigious journals such as Hepatology, Scientific Reports and Journal of Hepatology.

In The Last Decade

Shenghan Wang

17 papers receiving 293 citations

Peers

Shenghan Wang
Khadija Rebbani Morocco
Keith C.K. Lau Canada
Koji Yamashita Japan
Du Cheng China
Jie Bai China
Marie‐Anne Meier Switzerland
Carolina González Spain
Jizheng Chen China
Linda K. Hong United States
Guangze Liu China
Khadija Rebbani Morocco
Shenghan Wang
Citations per year, relative to Shenghan Wang Shenghan Wang (= 1×) peers Khadija Rebbani

Countries citing papers authored by Shenghan Wang

Since Specialization
Citations

This map shows the geographic impact of Shenghan Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shenghan Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shenghan Wang more than expected).

Fields of papers citing papers by Shenghan Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shenghan Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shenghan Wang. The network helps show where Shenghan Wang may publish in the future.

Co-authorship network of co-authors of Shenghan Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Shenghan Wang. A scholar is included among the top collaborators of Shenghan Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shenghan Wang. Shenghan Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Li, et al.. (2025). GCN5L1 Aggravates Postherpetic Neuralgia Through Regulating Microglial Mitochondrial Fission–Fusion Homeostasis. Journal of Cellular and Molecular Medicine. 29(18). e70861–e70861.
2.
Pan, Li, Shenghan Wang, H. L. Zhuang, et al.. (2025). Decoding disease–specific ageing mechanisms through pathway-level epigenetic clock: insights from multi-cohort validation. EBioMedicine. 118. 105829–105829.
3.
4.
Liu, Huan, Shenghan Wang, Zhifang Huang, et al.. (2025). Unraveling genetic risk contributions to nonverbal status in autism spectrum disorder probands. Behavioral and Brain Functions. 21(1). 15–15.
5.
Song, Zhijian, Xiaobing Lu, Li Pan, et al.. (2025). Epigenetic signatures of accelerated aging and immune dysregulation in youth with social anxiety disorder. Behavioural Brain Research. 494. 115729–115729.
6.
Zheng, Lihua, Lide Yao, Shiping Chen, et al.. (2025). Cross-kingdom gut microbiota signatures and their associations with clinical phenotypes in adolescents with bipolar depression. Journal of Affective Disorders. 394(Pt A). 120399–120399. 1 indexed citations
7.
Gao, Chen, et al.. (2025). The association between emphysema detected on computed tomography and increased risk of lung cancer: a systematic review and meta-analysis. Quantitative Imaging in Medicine and Surgery. 15(3). 2193–2208.
8.
9.
Ning, Shaowei, Xiaoyan Xu, Shenghan Wang, et al.. (2024). Comparative analysis of machine learning models and explainable AI for agriculture drought prediction: A case study of the Ta-pieh mountains. Agricultural Water Management. 306. 109176–109176. 5 indexed citations
10.
Sun, Cheng‐Pu, Mi‐Hua Tao, Hui‐Lin Wu, et al.. (2024). Major HBV splice variant encoding a novel protein important for infection. Journal of Hepatology. 80(6). 858–867. 7 indexed citations
11.
12.
Zhang, Shunjie, et al.. (2024). BioM2: biologically informed multi-stage machine learning for phenotype prediction using omics data. Briefings in Bioinformatics. 25(5). 4 indexed citations
13.
Liu, Jia, Shenghan Wang, Yong Yang, et al.. (2024). Real-world retrospective study of prostate-specific antigen and safety assessment with darolutamide plus androgen deprivation therapy for metastasis hormone-sensitive prostate cancer. Translational Andrology and Urology. 13(3). 433–441. 2 indexed citations
14.
15.
Zhang, Bao, Shenghan Wang, Zhichao Fu, et al.. (2023). Single-cell RNA sequencing reveals intratumoral heterogeneity and potential mechanisms of malignant progression in prostate cancer with perineural invasion. Frontiers in Genetics. 13. 1073232–1073232. 8 indexed citations
16.
Liu, Wei, Shuo Li, Lili Jiang, et al.. (2023). Racial disparities in conditional survival of patients with bladder cancer: a population-based study. BMC Urology. 23(1). 122–122. 3 indexed citations
17.
Wang, Pengyan, et al.. (2021). Identification of Novel COVID-19 Biomarkers by Multiple Feature Selection Strategies. Computational and Mathematical Methods in Medicine. 2021. 1–8. 3 indexed citations
18.
Shao, Lijun, Hong‐Chen Fu, Shenghan Wang, et al.. (2020). Identification of recently identified tick-borne viruses (Dabieshan tick virus and SFTSV) by metagenomic analysis in ticks from Shandong Province, China. Journal of Infection. 81(6). 973–978. 18 indexed citations
19.
Mutgan, Ayse Ceren, et al.. (2018). Insulin/IGF-driven cancer cell-stroma crosstalk as a novel therapeutic target in pancreatic cancer. Molecular Cancer. 17(1). 66–66. 84 indexed citations
20.
Wang, Shenghan, Shiou‐Hwei Yeh, Wei–Hsiang Lin, et al.. (2009). Identification of androgen response elements in the enhancer I of hepatitis B virus: A mechanism for sex disparity in chronic hepatitis B #. Hepatology. 50(5). 1392–1402. 144 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Khadija Rebbani Breakdown of academic impact, for papers by Keith C.K. Lau Breakdown of academic impact, for papers by Koji Yamashita Breakdown of academic impact, for papers by Du Cheng Breakdown of academic impact, for papers by Jie Bai Breakdown of academic impact, for papers by Marie‐Anne Meier Breakdown of academic impact, for papers by Carolina González Breakdown of academic impact, for papers by Jizheng Chen Breakdown of academic impact, for papers by Linda K. Hong Breakdown of academic impact, for papers by Guangze Liu
Rankless by CCL
2026